Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study)

Human gut microbiome is a promising target for managing type 2 diabetes (T2D). Measures altering gut microbiota like oral intake of probiotics or berberine (BBR), a bacteriostatic agent, merit metabolic homoeostasis. We hence conducted a randomized, double-blind, placebo-controlled trial with newly...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yifei, Gu, Yanyun, Ren, Huahui, Wang, Shujie, Zhong, Huanzi, Zhao, Xinjie, Ma, Jing, Gu, Xuejiang, Xue, Yaoming, Huang, Shan, Yang, Jialin, Chen, Li, Chen, Gang, Qu, Shen, Liang, Jun, Qin, Li, Huang, Qin, Peng, Yongde, Li, Qi, Wang, Xiaolin, Kong, Ping, Hou, Guixue, Gao, Mengyu, Shi, Zhun, Li, Xuelin, Qiu, Yixuan, Zou, Yuanqiang, Yang, Huanming, Wang, Jian, Xu, Guowang, Lai, Shenghan, Li, Junhua, Ning, Guang, Wang, Weiqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538905/
https://www.ncbi.nlm.nih.gov/pubmed/33024120
http://dx.doi.org/10.1038/s41467-020-18414-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538905/
https://www.ncbi.nlm.nih.gov/pubmed/33024120
http://dx.doi.org/10.1038/s41467-020-18414-8

Ejemplares similares